Sign inGet started

Session R.A. II

Insider CIK 1701846 · AVXS Sr. VP, Corp Strategy · TSHA President and CEO, Director, 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
TSHA Taysha Gene Therapies, Inc S Sale2023-07-132023-07-145,344$0.70 $3.7K8,871,747SEC↗
TSHA Taysha Gene Therapies, Inc S Sale2023-07-122023-07-1480,528$0.71 $57.2K8,877,091SEC↗
TSHA Taysha Gene Therapies, Inc S Sale2023-06-232023-06-2618,100$0.70 $12.7K8,957,619SEC↗
TSHA Taysha Gene Therapies, Inc S Sale2023-06-222023-06-2610,508$0.70 $7.4K8,975,719SEC↗
TSHA Taysha Gene Therapies, Inc S Sale2023-06-212023-06-22138,962$0.70 $97.3K8,986,227SEC↗
TSHA Taysha Gene Therapies, Inc S Sale2023-06-202023-06-22295,653$0.71 $209.9K9,125,189SEC↗
TSHA Taysha Gene Therapies, Inc D To issuer deriv2023-03-062023-03-08199,500— $00SEC↗
TSHA Taysha Gene Therapies, Inc J Other2023-03-062023-03-08251,296— $09,420,842SEC↗
TSHA Taysha Gene Therapies, Inc A Award deriv2022-11-102022-12-23199,500— $0199,500SEC↗
TSHA Taysha Gene Therapies, Inc A Award deriv2022-02-232022-02-25217,850— $0217,850SEC↗
TSHA Taysha Gene Therapies, Inc P Buy2021-11-232021-12-0826,008$12.65 $329.0K9,190,920SEC↗
TSHA Taysha Gene Therapies, Inc P Buy2021-11-232021-12-0816,510$12.12 $200.1K9,164,912SEC↗
TSHA Taysha Gene Therapies, Inc A Award deriv2021-01-192021-01-20199,700— $0199,700SEC↗
AVXS AveXis, Inc. D To issuer deriv2018-05-152018-05-156,572— $00SEC↗
AVXS AveXis, Inc. D To issuer deriv2018-05-152018-05-151,282— $00SEC↗
AVXS AveXis, Inc. D To issuer deriv2018-05-152018-05-1535,950— $00SEC↗
AVXS AveXis, Inc. D To issuer2018-05-152018-05-151,667— $00SEC↗
AVXS AveXis, Inc. A Award deriv2018-03-132018-03-276,572— $06,572SEC↗
AVXS AveXis, Inc. A Award2018-03-132018-03-271,667— $01,667SEC↗
AVXS AveXis, Inc. A Award deriv2017-05-102017-05-121,282— $01,282SEC↗
AVXS AveXis, Inc. A Award deriv2017-03-202017-03-2335,950— $035,950SEC↗